ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 161 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $274,000 | -22.6% | 7,800 | +1.3% | 0.02% | -19.4% |
| Q1 2022 | $354,000 | +5800.0% | 7,701 | +7678.8% | 0.03% | – |
| Q4 2021 | $6,000 | -97.0% | 99 | -95.8% | 0.00% | -100.0% |
| Q2 2021 | $197,000 | +245.6% | 2,382 | +216.3% | 0.02% | +150.0% |
| Q4 2020 | $57,000 | +5600.0% | 753 | +1221.1% | 0.01% | +500.0% |
| Q1 2020 | $1,000 | -98.8% | 57 | -98.7% | 0.00% | -83.3% |
| Q3 2018 | $81,000 | -1.2% | 4,235 | -30.0% | 0.01% | 0.0% |
| Q2 2018 | $82,000 | – | 6,047 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |